Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127055001 | 12705500 | 1 | I | 20160826 | 20160901 | 20160901 | EXP | CA-ORION CORPORATION ORION PHARMA-TREX2016-1499 | ORION | 54.00 | YR | F | Y | 0.00000 | 20160901 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127055001 | 12705500 | 1 | PS | METHOTREXATE (TRADE NAME UNKNOWN) | METHOTREXATE | 1 | Unknown | U | 0 | ||||||||||
| 127055001 | 12705500 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | ||||||||||
| 127055001 | 12705500 | 3 | SS | CELEBREX | CELECOXIB | 1 | Unknown | U | 0 | CAPSULE, HARD | |||||||||
| 127055001 | 12705500 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | U | 0 | 5 | MG | TABLET | BID | ||||||
| 127055001 | 12705500 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | U | 0 | 10 | MG | TABLET | BID | ||||||
| 127055001 | 12705500 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 127055001 | 12705500 | 7 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | U | 0 | ||||||||||
| 127055001 | 12705500 | 8 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | U | 0 | ||||||||||
| 127055001 | 12705500 | 9 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 127055001 | 12705500 | 10 | SS | VIOXX | ROFECOXIB | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127055001 | 12705500 | 1 | Rheumatoid arthritis |
| 127055001 | 12705500 | 2 | Rheumatoid arthritis |
| 127055001 | 12705500 | 3 | Rheumatoid arthritis |
| 127055001 | 12705500 | 4 | Rheumatoid arthritis |
| 127055001 | 12705500 | 6 | Rheumatoid arthritis |
| 127055001 | 12705500 | 8 | Rheumatoid arthritis |
| 127055001 | 12705500 | 9 | Rheumatoid arthritis |
| 127055001 | 12705500 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127055001 | 12705500 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127055001 | 12705500 | Bone erosion | |
| 127055001 | 12705500 | Drug ineffective | |
| 127055001 | 12705500 | Nasopharyngitis | |
| 127055001 | 12705500 | Rheumatoid arthritis | |
| 127055001 | 12705500 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |